Recombinant Antibody No Further a Mystery
Cell Signaling Technology (CST) has utilised recombinant antibody output because 2007. The approaches’ gain is that the antibodies are “extremely amenable to engineering,” says Katie Crosby, who directs immunohistochemistry at CST. 1 may manipulate the heavy and light chain or use unique spine structures for your antibody. Promoters modulate